HelixFold-Multimer精准预测抗原抗体结构，助力抗体药物研发。
Precise Antigen-Antibody Structure Predictions Enhance Antibody Development with HelixFold-Multimer
- 基于AlphaFold框架改进，专为抗原抗体复合物设计
- 在结合位点预测和相互作用分析上精度显著提升
- 适合抗体药物研发人员和免疫学研究者使用
准确预测抗原-抗体结构对推动免疫学和治疗性抗体开发至关重要，有助于阐明免疫应答的分子机制。尽管深度学习模型如AlphaFold和RoseTTAFold取得进展，但因抗原抗体复合物具有独特进化特征，其建模仍具挑战。本文提出的HelixFold-Multimer在此基础上优化，显著提升抗原-抗体复合物的结构预测精度。该模型不仅优于其他现有方法，还能更精确识别结合位点、改善相互作用预测，并支持治疗性抗体的高效设计。这些成果凸显了HelixFold-Multimer在抗体研究与药物创新中的潜力。
原文摘要 · Abstract (English)
The accurate prediction of antigen-antibody structures is essential for advancing immunology and therapeutic development, as it helps elucidate molecular interactions that underlie immune responses. Despite recent progress with deep learning models like AlphaFold and RoseTTAFold, accurately modeling antigen-antibody complexes remains a challenge due to their unique evolutionary characteristics. HelixFold-Multimer, a specialized model developed for this purpose, builds on the framework of AlphaFold-Multimer and demonstrates improved precision for antigen-antibody structures. HelixFold-Multimer not only surpasses other models in accuracy but also provides essential insights into antibody development, enabling more precise identification of binding sites, improved interaction prediction, and enhanced design of therapeutic antibodies. These advances underscore HelixFold-Multimer's potential in supporting antibody research and therapeutic innovation.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品；中文卡片由大模型生成，请以原文为准。